K
Katy J.L. Bell
Researcher at University of Sydney
Publications - 136
Citations - 3024
Katy J.L. Bell is an academic researcher from University of Sydney. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 22, co-authored 106 publications receiving 1895 citations. Previous affiliations of Katy J.L. Bell include Bond University & Westmead Hospital.
Papers
More filters
Journal ArticleDOI
A methods review of posttrial follow-up studies of cardiovascular prevention finds potential biases in estimating legacy effects.
TL;DR: Post-trial studies may provide valuable information for investigating legacy effects, but better reporting of results is needed to realize their full potential and robust methods of data collection and analysis may address the risk of selection and confounding biases in post- trial studies.
Journal ArticleDOI
Direct-to-consumer pathology tests and medical overuse in Australia: Ethical, clinical and public health implications
TL;DR: Shih et al. as discussed by the authors conducted a systematic search of Google and Google shopping for direct-to-consumer (DTC) tests advertised online in Australia and identified 484 DTC testing products for sale.
Journal ArticleDOI
A counterargument to encounter frequency and target achievement: Measurement variability
Journal ArticleDOI
Adenotonsillectomy and adenoidectomy in children: The impact of timing of surgery and post‐operative outcomes
TL;DR: To investigate the impact of adenotonsillectomy (ADT) and adenoidectomy (AD) on child health and evaluated their post‐operative complications, a large number of children were referred for surgery.
Journal ArticleDOI
Strategies to Improve Adherence to Skin Self-examination and Other Self-management Practices in People at High Risk of Melanoma: A Scoping Review of Randomized Clinical Trials.
Deonna M. Ackermann,Karen Bracken,Monika Janda,Robin M. Turner,Jolyn Hersch,Dorothy Drabarek,Katy J.L. Bell +6 more
TL;DR: In this paper , a scoping review aimed to describe strategies to improve adherence to self-management practices in randomized clinical trials of people at high risk of melanoma and measurement and reporting of adherence data in these trials.